Compositions and methods

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9480735
APP PUB NO 20140314802A1
SERIAL NO

14283727

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to a polypeptide which comprises: (i) an Rv2386c protein sequence; (ii) a variant of an Rv2386c protein sequence; of (iii) an immunogenic fragment of an Rv2386c protein sequence. In other aspects the invention is directed to associated polynucleotides, fusion proteins and methods for the treatment or prevention of tuberculosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GLAXO GROUP LIMITED;SMITHKLINE BEECHAM BIOLOGICALS S.A.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brown, James Collegeville, US 205 2256
Mettens, Pascal Rixensart, BE 23 66
Murphy, Dennis Collegeville, US 43 268

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 1, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 1, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00